» Articles » PMID: 20045480

UDP-GlC:glycoprotein Glucosyltransferase-glucosidase II, the Ying-yang of the ER Quality Control

Overview
Date 2010 Jan 5
PMID 20045480
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The N-glycan-dependent quality control of glycoprotein folding prevents endoplasmic to Golgi exit of folding intermediates, irreparably misfolded glycoproteins and incompletely assembled multimeric complexes. It also enhances folding efficiency by preventing aggregation and facilitating formation of proper disulfide bonds. The control mechanism essentially involves four components, resident lectin-chaperones that recognize monoglucosylated polymannose glycans, a lectin-associated oxidoreductase acting on monoglucosylated glycoproteins, a glucosyltransferase that creates monoglucosytlated epitopes in protein-linked glycans and a glucosidase that removes the glucose units added by the glucosyltransferase. This last enzyme is the only mechanism component sensing glycoprotein conformations as it creates monoglucosylated glycans exclusively in not properly folded species or in not completely assembled complexes. The glucosidase is a dimeric heterodimer composed of a catalytic subunit and an additional one that is partially responsible for the ER localization of the enzyme and for the enhancement of the deglucosylation rate as its mannose 6-phosphate receptor homologous domain presents the substrate to the catalytic site. This review deals with our present knowledge on the glucosyltransferase and the glucosidase.

Citing Articles

The Loop-In Binding Mode of Dihydroorotase: Implications for Ligand Binding and Therapeutic Targeting.

Huang C Int J Mol Sci. 2025; 26(3).

PMID: 39941127 PMC: 11818841. DOI: 10.3390/ijms26031359.


The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis.

Davies J, Plate L bioRxiv. 2024; .

PMID: 38895409 PMC: 11185542. DOI: 10.1101/2024.06.02.597051.


Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.

Pavlakis E, Neumann M, Merle N, Wieboldt R, Wanzel M, Ponath V J Exp Clin Cancer Res. 2023; 42(1):203.

PMID: 37563605 PMC: 10413714. DOI: 10.1186/s13046-023-02785-z.


Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy.

Yue J, Huang R, Lan Z, Xiao B, Luo Z Biomark Res. 2023; 11(1):54.

PMID: 37231524 PMC: 10214721. DOI: 10.1186/s40364-023-00491-8.


Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.

Karade S, Franco E, Rojas A, Hanrahan K, Kolesnikov A, Yu W J Med Chem. 2023; 66(4):2744-2760.

PMID: 36762932 PMC: 10278443. DOI: 10.1021/acs.jmedchem.2c01750.


References
1.
Hoffrogge R, Beyer S, Hubner R, Mikkat S, Mix E, Scharf C . 2-DE profiling of GDNF overexpression-related proteome changes in differentiating ST14A rat progenitor cells. Proteomics. 2006; 7(1):33-46. DOI: 10.1002/pmic.200600614. View

2.
Ugalde R, Staneloni R, LELOIR L . Microsomal glucosidases acting on the saccharide moiety of the glucose-containing dolichyl diphosphate oligosaccharide. Biochem Biophys Res Commun. 1979; 91(3):1174-81. DOI: 10.1016/0006-291x(79)92003-5. View

3.
Labriola C, Cazzulo J, Parodi A . Retention of glucose units added by the UDP-GLC:glycoprotein glucosyltransferase delays exit of glycoproteins from the endoplasmic reticulum. J Cell Biol. 1995; 130(4):771-9. PMC: 2199956. DOI: 10.1083/jcb.130.4.771. View

4.
Anji A, Kumari M . A novel RNA binding protein that interacts with NMDA R1 mRNA: regulation by ethanol. Eur J Neurosci. 2006; 23(9):2339-50. DOI: 10.1111/j.1460-9568.2006.04776.x. View

5.
Hammond C, Braakman I, Helenius A . Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci U S A. 1994; 91(3):913-7. PMC: 521423. DOI: 10.1073/pnas.91.3.913. View